Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter T Beernink

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Journal of Immunology (Baltimore, Md. : 1950)|February 18, 2011
A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccinationPeter T Beernink, Jutamas Shaughnessy, Emily M Braga, et al.
Nature Communications|February 8, 2018
Crystal structure reveals vaccine elicited bactericidal human antibody targeting a conserved epitope on meningococcal fHbpJacinto López-Sagaseta, Peter T Beernink, Federica Bianchi, et al.
Msphere|July 5, 2019
Anti-Factor H Antibody Reactivity in Young Adults Vaccinated with a Meningococcal Serogroup B Vaccine Containing Factor H Binding ProteinKelsey Sharkey, Peter T Beernink, Joanne M Langley, et al.
The Biochemical Journal|October 28, 2016
Neisseria meningitidis factor H-binding protein bound to monoclonal antibody JAR5: implications for antibody synergyEnrico Malito, Paola Lo Surdo, Daniele Veggi, et al.
Msphere|April 8, 2025
Methods to evaluate the performance of a multicomponent meningococcal serogroup B vaccineRay Borrow, Laura Tomasi Cont, Daniela Toneatto, et al.
Science Translational Medicine|June 21, 2023
An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal diseaseChristina Dold, Leanne Marsay, Nelson Wang, et al.
JACS Au|July 26, 2024
Gonococcal Mimitope Vaccine Candidate Forms a Beta-Hairpin Turn and Binds Hydrophobically to a Therapeutic Monoclonal AntibodyPeter T Beernink, Cristina Di Carluccio, Roberta Marchetti, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2026
An Adenoviral Vectored Vaccine Protects Mice Against Aerosol Challenge with Yersinia pestisChristina Dold, Laura Silva-Reyes, Young Chan Kim, et al.
Science Translational Medicine|May 7, 2025
A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccineChristina Dold, Blanché Oguti, Laura Silva-Reyes, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Journal of Immunology (Baltimore, Md. : 1950)|February 18, 2011
A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccinationPeter T Beernink, Jutamas Shaughnessy, Emily M Braga, et al.
Nature Communications|February 8, 2018
Crystal structure reveals vaccine elicited bactericidal human antibody targeting a conserved epitope on meningococcal fHbpJacinto López-Sagaseta, Peter T Beernink, Federica Bianchi, et al.
Msphere|July 5, 2019
Anti-Factor H Antibody Reactivity in Young Adults Vaccinated with a Meningococcal Serogroup B Vaccine Containing Factor H Binding ProteinKelsey Sharkey, Peter T Beernink, Joanne M Langley, et al.
The Biochemical Journal|October 28, 2016
Neisseria meningitidis factor H-binding protein bound to monoclonal antibody JAR5: implications for antibody synergyEnrico Malito, Paola Lo Surdo, Daniele Veggi, et al.
Msphere|April 8, 2025
Methods to evaluate the performance of a multicomponent meningococcal serogroup B vaccineRay Borrow, Laura Tomasi Cont, Daniela Toneatto, et al.
Science Translational Medicine|June 21, 2023
An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal diseaseChristina Dold, Leanne Marsay, Nelson Wang, et al.
JACS Au|July 26, 2024
Gonococcal Mimitope Vaccine Candidate Forms a Beta-Hairpin Turn and Binds Hydrophobically to a Therapeutic Monoclonal AntibodyPeter T Beernink, Cristina Di Carluccio, Roberta Marchetti, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2026
An Adenoviral Vectored Vaccine Protects Mice Against Aerosol Challenge with Yersinia pestisChristina Dold, Laura Silva-Reyes, Young Chan Kim, et al.
Science Translational Medicine|May 7, 2025
A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccineChristina Dold, Blanché Oguti, Laura Silva-Reyes, et al.
Pageof 5